Cite
Singhal N, Praveen VP, Bhavani N, et al. Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects. Indian J Endocrinol Metab. 2016;20(2):157-61doi: 10.4103/2230-8210.176360.
Singhal, N., Praveen, V. P., Bhavani, N., Menon, A. S., Menon, U., Abraham, N., Kumar, H., JayKumar, R. V., Nair, V., Sundaram, S., & Sundaram, P. (2016). Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects. Indian journal of endocrinology and metabolism, 20(2), 157-61. https://doi.org/10.4103/2230-8210.176360
Singhal, Neha, et al. "Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects." Indian journal of endocrinology and metabolism vol. 20,2 (2016): 157-61. doi: https://doi.org/10.4103/2230-8210.176360
Singhal N, Praveen VP, Bhavani N, Menon AS, Menon U, Abraham N, Kumar H, JayKumar RV, Nair V, Sundaram S, Sundaram P. Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):157-61. doi: 10.4103/2230-8210.176360. PMID: 27042408; PMCID: PMC4792013.
Copy
Download .nbib